ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, UBE2D3, MUM1, CIB1, BRCA1, PARK7, SMC6, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, POLH, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, RFC1, NCOA6, PARP2, RFC2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PAXIP1, PNKP, GPS1, COPS7B, COPS7A, XPC, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RNF138, RAD21, UBR5, ABL1, POLR2E, RAD54L, POLR2G, USP51, POLR2I, POLR2K, FANCI, POLQ, XRCC6, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC5L, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, TTC5, UBE2T, POLE2, RFWD3, CDK2, ERCC5, MNAT1]
GO:0015671;oxygen transport;5.0;1.0;0.7902410118609202;9.628524252492122;26.519296615914115;7.138016298065211;8.875769919171911E-4;0.6552794972956795;[HBZ, MYC, HBE1]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[FGG, PRKCD, CD9]
GO:0007130;synaptonemal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.07517101545795;6.781341354126479;0.0029477967113796214;0.6699184248047958;[HORMAD1]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCD]
GO:1905025;negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential;12.0;0.9326813400603323;0.9144609826203107;9.607904965289386;975.4476452163691;9.777073627680469;0.03264735483950576;0.9481203125901445;[KCNE3]
GO:1901741;positive regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.2013099653272;6.8867018697843045;0.011821329983997786;0.7484268790654467;[CXCL9, IL4R, TNFSF14, FLT3LG, SCGB3A1]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[CAPZB, PRKCD]
GO:1903765;negative regulation of potassium ion export across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;488.145687169157;9.777073627680469;0.01633779684695517;0.9324289523296623;[KCNE3]
GO:0042412;taurine biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;394.79154258331346;9.083926447120524;0.013213317640942513;0.7876727335416686;[CSAD]
GO:0042138;meiotic DNA double-strand break formation;7.0;0.8933024483968273;0.7975705894556142;9.52844079393514;140.69855703909965;7.9853141584524145;0.004709054083618228;0.7592887026755414;[HORMAD1]
GO:0006957;complement activation, alternative pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.212124270218933;0.006695884470798082;0.7438283705770736;[C3, CFH, CFB]
GO:0010818;T cell chemotaxis;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;127.60944988880927;7.292166977892469;0.004270973446729658;0.747921758369865;[CXCL9, CXCL11, PIK3CG, CCR2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ABCB4, PTEN, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, PLAU, MYC, FUNDC1, CASP3, UCP3, NPPA, LMNA, UBQLN1, CAPN2, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, PRKCE, ARNT, AGTRAP, SIRT2, NR4A2, SFRP1, TBL2, DDIT4, CAT, HYOU1, TEK, CD24, PAM, KCNK3]
GO:0048240;sperm capacitation;4.0;1.0;0.75;9.628524252492122;67.15086498286243;6.558197802812269;0.0022474790191214893;0.5853865406232063;[SLC26A8]
GO:0031639;plasminogen activation;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;103.96951844736539;7.379178354882098;0.003479766215941568;0.7523715242355574;[FGA, PLAU, FGG]
GO:2000753;positive regulation of glucosylceramide catabolic process;8.0;1.0;0.875;9.628524252492122;623.5788865307586;9.777073627680469;0.0208706241476218;0.875;[PRKCD]
GO:0034587;piRNA metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.72069011476309;6.8867018697843045;0.003940005556398338;0.7271862538851576;[PIWIL4]
GO:2000755;positive regulation of sphingomyelin catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1040.6474307865747;9.777073627680469;0.034829532986543094;0.9152410118609203;[PRKCD]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[CYB5R1, SLC26A8, AQP1]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[HDAC3, JUP, BAG3, HYAL2, TPR, UBR5, PRKCD, ECT2, TMEM173]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[SLC12A2, KCNG1, KCNK6, KCND1, KCNE3, KCNK12, KCNA3, PKD2L1, ATP1B2, PKD2, MTMR6, AQP1, SLC9A6, SLC9A8, KCNN3, KCNK3]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[PTGER4, CUEDC2, SERPINF1, PRKCD, GPS2, RORA, METRNL, AGER, NFKB1, IL22RA2, BCR, ABR, NLRP12, ADORA2A, NLRP7, PBK, NLRP3, TEK]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY, SQLE, EBP, NSDHL, G6PD, CYB5R3, GGPS1, LBR]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[DIABLO, PRKCD, ARL6IP5, ZNF622, PDK1, MAP3K5]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, CIB1, CALML4, BICD1, TUBA1C, TUBA1B, TUBB6, KIF19, NUF2, ZNF207, FBXO5, NEFH, MAP1S, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KATNAL1, MAP7D1, MYH9, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, GAPDH, KPNB1, GAS8, PAFAH1B1, MCPH1, BIRC3, HDAC3, DCTN2, TUBGCP2, VPS4B, TUBD1, CCNB1, SPAST, KIF3B, LMNA, DISC1, CLASP1, MARK2, BBS2, UBE2B, CEP350, NDC80, RAB11A, CCDC88B, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, TTLL3, FES, KIF4A, CENPJ, TBCE, FGFR1OP, SPRY1, CALM1, SPC25]
GO:0061049;cell growth involved in cardiac muscle cell development;4.0;0.9326813400603323;0.7163406700301662;9.4949928598676;32.430622850889186;7.697632086000634;0.0010854237611535892;0.6436572628545723;[NPPA, PDLIM5]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PTPRE, PRKCD, RELA]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CXCL9, CXCL11, HIST1H2BJ, DEFB1, RNASE3, GAPDH, HIST1H2BC]
GO:0014909;smooth muscle cell migration;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;22.014357120524497;7.474488534686424;7.368007211888268E-4;0.7053660038532718;[PDGFRB, PLAU, ITGB3, AAMP]
GO:0046470;phosphatidylcholine metabolic process;7.0;0.7508913569872202;0.7263650437508107;9.129533086373135;183.95696187605128;5.500407508664414;0.006156873963474197;0.6322104610454062;[CETP, PLA2G12A, CHKB, FABP5, CHKA, STARD7, STARD10, PEMT, DBI, GDPD3, PNPLA6]
GO:0030816;positive regulation of cAMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.526741558182179;1396.5025295312637;6.139487467954083;0.04673968289273128;0.7292146864874571;[CXCL9, CXCL11, TIMP2, CALM3, CALM1, CALM2, TSHR]
GO:0071243;cellular response to arsenic-containing substance;4.0;0.8653626801206646;0.6826813400603323;9.377209824211215;38.7152913866576;7.138016298065211;0.0012957659612112835;0.6150384854347593;[GSTO2, ZFAND2A, MKNK2, PPIF, MAPK13]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, PPP1R15A, PTBP1, CDCA2, PPP1R12A, PPP1R7, FCRL3, PRKCD, CALM3, PPP2R5D, CALM1, CALM2]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[CAMK2D, JUP, KCNE3, CAV1]
GO:0019752;carboxylic acid metabolic process;5.0;0.32428578997777324;0.4523839068498069;5.309370859636751;42.504421911339485;2.9735683700721314;0.0014225847498763097;0.4423094365914798;[CARS, SLC23A2, AHCYL1, ACSM3, CPOX, PARK7, ALKBH7, GBA2, ALDH1L2, GLS, NARS, FADS3, PPAT, NARS2, SEPHS1, FADS1, EARS2, ST6GAL1, ACOT7, GPT2, ACSL6, UGT2B17, SARS, AARSD1, CEL, PRKAB1, ALDH3A2, ACLY, KARS, MTHFD1, MTHFD2L, ACOT2, SUCLG1, ALDH7A1, SLC27A2, HPD, ACOT4, ATF4, SLC35D1, TARSL2, LIAS, ADIPOR2, ACACA, C3, SGPL1, CYB5R3, CHST12, ST3GAL1, PCK2, YARS, XBP1, OSBPL2, IDH2, PYCR1, MCAT, CS, MSRA, QARS, VNN3, PEMT, DEGS1, ACO1, ACO2, SERINC3, FARSA, PAM, GPI, ABCD3, ADPGK, ETFA, ETFB, BRCA1, CSAD, AACS, HK3, CPT2, NNT, RARS, HYAL2, IDH3B, ATP7A, GUSB, HIBCH, BCKDHA, LRRC47, ABCC1, TPI1, ABCC2, SYK, GSTO2, ELOVL5, ABCC5, DCXR, ATPIF1, BCKDHB, CAD, DARS2, ELOVL6, BPGM, UGDH, ALDH5A1, ACOX2, PCCA, NDUFS6, DPYD, ALDOC, DAGLB, ALDOA, GAPDH, MGLL, UGT2B7, ITIH2, ECHS1, OAT, MRPS36, HSD17B4, HSD17B8, CLN3, UGP2, MTHFD1L, UCP3, HARS, HSD3B7, EGLN2, CTNS, NMNAT3, AGMAT, PER2, GPAM, DHRS9, PSAT1, MARS]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[RNF138, ZFAND2A, CAV1, UBQLN1, RAD23A, TRIB3, LONRF3, PRICKLE1, SIRT2, RNF166]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, SYS1, RPL3, NUP107, RTKN, NCF1, RAB3D, UBE2D3, BUB1B, ZDHHC6, ABCA12, IPO4, RPS15, IPO8, IPO9, LAMP2, LONP2, KPNA4, GSTK1, RPS9, RPS7, COG3, PAQR3, TOMM34, RPSA, ARMCX3, NUP93, RAB35, MYADM, ACOT2, CHMP4B, RAB38, RPL29, SLC27A2, KPNB1, ACOT4, SEH1L, TOR1AIP2, AGER, FBLN5, NCKIPSD, UGT8, BAG4, RAD21, SSR1, RAB6A, FAM83D, S100A10, BBS2, TOR1A, PMM1, JUP, XRCC5, CAV1, RCC2, RAB3IP, PMM2, IFT122, NUP153, TIMM44, UBAC2, CDK5, GOLGB1, DCP1A, CD24, EZH2, ARF4, TRAM1, PIGU, ITGB2, SRP54, WASL, PTPRK, TRAM2, BICD1, GPHN, SEC61A2, ANKRD9, NIPBL, SIN3A, NUP62, TMEM107, SH3PXD2B, TMED2, TNPO1, TNPO2, ARL5A, TNPO3, RAB8B, GRIPAP1, SEC13, FCER1G, H2AFY, SYK, SSR2, SSR3, ZDHHC12, SEPT2, GAK, ACOX2, RER1, AGPS, CAT, EXOC4, EXOC3, POT1, PIK3C3, MAPRE3, MAPRE1, VAMP5, GAS8, EXOC1, MCPH1, PPP1R15A, BECN1, LAMA5, TOMM40, DCTN2, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, PRICKLE1, RGPD1, TM9SF4, AP3M1, WRN, RAB40C, PES1, LMNA, HEATR3, MFN2, BID, RAE1, RPL19, PEX16, TIMM8B, UBL4A, MBTPS1, SEPT11, TMEM30A, PEX19, ANGPT1, AGK, RPL23A, GDAP1, RAB11A, DHRS4, TM9SF1, SPCS2, VAPA, SLMAP, VPS41, TSPAN17, RAB13, TAOK2, RAB3GAP2, RAB3GAP1]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, ITGB1, TCF7L2, IGFBP5, ANGPT1, CD80, PARK7, THBS1, VAV1, PIK3CG, TGFBR1, STK3, MTDH, BAG4, C1QBP, KIT, CPNE1, CCL19, TEK, MET, HBEGF]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[DUSP5, CAV1, GPS1, PAQR3, PRKCD, GPS2, PTPN22, DUSP14, PPP2CA, DUSP22, SFRP1, SFRP2, HYAL2, NUP62, STK38, SPRY1, PTPN6, CDK5RAP3]
GO:0090435;protein localization to nuclear envelope;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.85305034697331;7.697632086000634;0.0011665002294043187;0.7445766281117727;[TOR1AIP2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, CD80, LST1, SIRPG, PTEN, CIB1, PTPRK, COMT, PKD2, FLCN, ING2, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, TIMP2, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, TGFBR1, NME1, SFRP1, TWSG1, GAL, TFDP1, SFRP2, KARS, ADORA2A, RAPGEF1, RARA, TAX1BP3, B4GALT7, GAS8, SF1, BECN1, STK4, THBS1, STK3, TMEM127, TP53INP1, LMNA, MFN2, CSK, E2F7, TFAP2A, CDKN2D, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, WDR13, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, PEMT, MNDA, SPRY1, PTPN6, CNOT8, TRIM32]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, NSMCE2, PRKCD, SMC6, HRAS, ARNTL]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, CD40, SLC20A1, TRADD, SECTM1, CXXC5, RELA, MTDH, AKAP13, CASP8, TFG, CASP10, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TMED4, MAP3K3, UBE2I, PRKCE, ZDHHC13, TNFRSF10B, IRAK4, RHOC, ZDHHC17, CD4, VAPA, TNIP2, LTBR, TRIM32, CARD11, BIRC3]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[SCARB1, CETP, EBP, NSDHL, RXRA, CYB5R3, FDXR, SCAP, APOL1, SCARF1, LBR, APOL2, HSD3B7, STARD3, MBTPS1, G6PD, GGPS1, ERLIN2, CEL, ACLY, SQLE, SOAT1, SNX17, CAT, NFE2L1]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, CD40, PDCD6, TRADD, CIB1, BRCA1, BBC3, POLB, CASP8, CASP10, CASP3, DPF2, ARL6IP5, CASP2, EP300, IL12A, ITGAV, HRAS, APPL1, PDK1, MAP3K5, TNFRSF12A, RIPK3, PARP2, PRKCD, ERN1, DDIT4, TRIB3, ATF4, PPP1R15A, DIABLO, KRCC1, TFPT, SGPL1, ZMAT1, BAG3, PERP, MKNK2, TP53BP2, ABL1, RIPK1, ZNF622, BID, DEDD, XBP1, SIVA1, EYA2, CD70, CAV1, G0S2, TNFRSF10B, TNFRSF10A, P2RX7, P2RX4, BCL3, CD24]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[CXCL9, BTG1, TNFSF14, FLT3LG, HIF1AN, MAP3K5]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[UPF1, YTHDF3, FASTKD1, YWHAB, DIS3, PRKCD, YWHAZ, PUM2, FXR1, XRN1, DCP1A, TNPO1, EXOSC3, DCP2]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP2, NCKAP1, ACTR2, SYK, WIPF2, PRKCE, ARPC1A, PRKCD, WAS, WASL, VAV1, VAV2, NCKIPSD, FCGR3A, ARPC2, ELMO1, ABL1, NCKAP1L]
GO:0042157;lipoprotein metabolic process;5.0;0.7586651285174919;0.6695735761196662;8.999915593069748;47.85814540089318;6.221725566191056;0.001601769057033345;0.6084203466557585;[APOL4, APOL1, APOL2]
GO:0044334;canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition;9.0;1.0;0.896240625180289;9.628524252492122;34.305501416841174;9.083926447120524;0.0011481742594748403;0.8607930461318132;[TCF7L2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, STK16, DPF2, EP300, SOX8, SOX6, IER5, HMGN3, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, RUNX1, ARMCX3, SFRP2, IL23A, TBL1XR1, RFX4, HOXB4, ATF4, PAXIP1, MAX, ZNF24, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, PPARGC1B, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, THRA, CHD8, CHD7, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, HOXC10, MED12, FLCN, NIPBL, SIN3A, HYAL2, MLX, HRAS, TEAD2, ZNF485, MKL2, KLF13, RBM15, PPP1R12A, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, RARA, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPE, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, TCF7L2, NFYC, ATAD2, CDC5L, ARID3B, GRHL1, USF2, POMC, KLF6, NFIA, TNIP1, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, SSBP3, MIXL1]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CREBBP, FCER1G, RPS6KA5, SYK, PRKCD, EP300, KRAS, HRAS, NFKB1, RELA, CARD11]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP2, BTG2, PIWIL4, EIF4E3, EIF4A3, CASC3, RBM3, EIF4ENIF1, MTRF1, PAIP2B, C1QBP, UPF1, EIF5B, RPS9, IGFBP5, ITGA2, SECISBP2, MIF4GD, ILF3, XRN1, RARA, ETF1, EIF4E2, GAPDH, ATF4, PPP1R15A, MTPN, CDC123, POLDIP3, NOLC1, THBS1, FXR1, ATXN2, RXRA, CCL5, TPR, MKNK2, POLR2G, EIF2B4, KLHL25, YTHDF3, EIF2AK3, CNOT10, UPF3A, EIF2S1, PUM2, PER2, CNOT6, IL6, CNOT7, CNOT1, CAPRIN1, BCL3, CNOT3, ACO1, CNOT8, KBTBD8, LSM14A, EIF4G2, TNRC6A, CPEB4, TNRC6B]
GO:0009407;toxin catabolic process;4.0;0.6913464685778243;0.5956732342889122;8.458452999841867;64.99626524910956;8.16763571524637;0.0021753665050466492;0.6676932703116032;[GSTO2]
GO:0097104;postsynaptic membrane assembly;5.0;1.0;0.7902410118609202;9.628524252492122;57.45028169597201;7.57984905034425;0.001922809226467428;0.6778748447945537;[CEL]
GO:0097105;presynaptic membrane assembly;5.0;1.0;0.7902410118609202;9.628524252492122;57.45028169597201;7.474488534686424;0.001922809226467428;0.6724867031240476;[PTEN, CEL]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[STOML2, ITPR2, ATP2A2, PKD2L1, PKD2, CORO1A, CCL5, CDH23, PMPCB, ITGAV, CCL19, TRPM6, ATP13A1, CAV1, PRKCE, CACNA2D3, ATP2B4, TRPC4AP, BSPRY, P2RX7, P2RX4, GRIN3A, CDK5, NMUR1, ATP13A3]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[STOML2, ATP13A1, PRKCE, CACNA2D3, ATP2B4, ITPR2, ATP2A2, PKD2L1, PKD2, TRPC4AP, P2RX7, P2RX4, GRIN3A, PMPCB, ITGAV, CCL19, ATP13A3, TRPM6]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ITGB3, KIF14, PARK7, STK4, THBS1, STK3, ABL1, NEK1, NCKAP1L, RIPK1, CCL19, ECT2, MARK2, MAP3K5, MAP3K3, DUSP5, PRNP, MAP4K2, MAP3K1, DBNL, PDE6H, ANGPT1, RIPK3, SYK, PRKCD, ZFP91, TNFRSF10B, TNFRSF10A, PILRB, OXSR1, ADRA2C, MAPK8IP3, TGFBR1, SOD1, ERN1, P2RX7, CCDC88A, KARS, TAOK2, KIT, MADD, RAPGEF1, ADNP]
GO:0010874;regulation of cholesterol efflux;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;32.440617978830005;6.7325511899570465;0.0010857582890907373;0.719302980950052;[NFKBIA, CETP, GPS2, ABCA12]
GO:0010632;regulation of epithelial cell migration;7.0;0.6835726970475526;0.6927057137809769;8.935377071932177;51.82815421622313;4.458953633836253;0.0017346416793064688;0.5789504614541361;[SCARB1, GPI, CD40, BMPR2, ROCK2, ITGB3, PDCD6, PTEN, CIB1, THBS1, TBXA2R, TMSB4X, ABL1, CTSH, AAMP, CLASP1, ARSB, MAP3K3, STARD13, ANXA1, ANGPT1, JUP, ITGA2, SERPINF1, PRKCE, RAB11A, RHOB, VIL1, P2RX4, SP1, TEK, MET, HBEGF]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[TCF7L2, PRKCE, TM7SF3, AACS, BAIAP3, PCK2]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, STOML2, BTN2A1, WAS, PTPN22, BTN3A2, NFKB1, RELA, RC3H2, CD4, NFKBIZ, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, PAG1, HLA-DPA1, HLA-DQB1]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2CA, ERRFI1, SFRP1, SH3BP5L, SFRP2, SEMA4D, CAV1, HYAL2, PRKCD, FGFR1OP, PTPN6, CHMP6]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[GRIN3A, MAP1S, LST1, SCARF1]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[ANAPC13, FZR1, UBE2B, UBE2T, CDC26, CDC16, UBE2D3, ANAPC5, ANAPC11, UBE2L3]
GO:0060134;prepulse inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;45.20359748329822;7.212124270218933;0.0015129237271694644;0.6919486831672181;[GRIN3A, ADORA2A, PTEN]
GO:0061580;colon epithelial cell migration;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;24.971868181253015;9.777073627680469;8.357859548042604E-4;0.875;[ARSB]
GO:1900163;positive regulation of phospholipid scramblase activity;9.0;1.0;0.896240625180289;9.628524252492122;406.95467434623936;9.777073627680469;0.013620406714939737;0.896240625180289;[PRKCD]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[MYL4, DNAJB1, DNAJC7, TMSB4X, DNAJB11, TOR1AIP2, ATP1B2, DYNLL2, DNAL4, DNM2]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[ANAPC13, CCNF, UBE2D3, UBE3A, BRCA1, FBXO41, ANAPC11, UBE2L3, NPEPPS, FZR1, ZNRF2, RNF213, RNF138, CDC26, UBR5, TRIM69, LONRF3, TRIM27, RFFL, SKP2, C18orf25, RNF20, MYLIP, UBE2B, DTX3L, FBXW11, SYVN1, ZFP91, UBE4A, FBXL15, LNPEP, FBXL16, MARCH6, RC3H2, ITCH, SPSB1, UBE2T, CDC16, FBXL3, ANAPC5, TRIM32, THOP1, RNF166]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, CXCL11, ABL1, CALM3, CALM1, PKD2, CALM2, NTSR1]
GO:1903955;positive regulation of protein targeting to mitochondrion;10.0;0.9326813400603323;0.8815816818910864;9.597752593825367;662.5702871444865;6.311337724880743;0.022175631236180954;0.7380031166185408;[NPEPPS, USP36, UBL5, UBE2D3, VPS11, RHOU, UBE2L3]
GO:0006707;cholesterol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;394.5590965539014;7.292166977892469;0.013205537881525935;0.7238411236270654;[HSD3B7, SCARB1, SNX17, CEL, SCARF1]
GO:0010529;negative regulation of transposition;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;41.7579727432223;6.781341354126479;0.0013976017679800644;0.6370391240755715;[PIWIL4, APOBEC3F, ZNF93, APOBEC3H, APOBEC3A]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[IL4R, FCER1G, EXO1, BCL3, PRKCD, HLA-DQB1]
GO:0031047;gene silencing by RNA;8.0;0.7671156992804218;0.7585578496402109;9.168991923113682;70.59795582467933;5.885253329569843;0.002362850047416754;0.6759721289664703;[DDX17, CNOT6, PIWIL4, CNOT7, CNOT1, CNOT3, CNOT10, HELZ, CNOT8, SND1, TNRC6A, TNRC6B]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CXCL9, FCER1G, SYK, CCL20, ITGB2, VAV1, PIK3CG, PREX1, CXCL11, CCL5, NCKAP1L, CCL19]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[FGA, TCF7L2, EYA2, TRADD, FGG, TNFRSF10B, TNFRSF10A, BRCA1, PARK7, THBS1, RELA, TGFBR1, SFRP2, CASP8, LMNA, TMBIM1, RIPK1, ITGAV, BIRC6, RFFL]
GO:0019852;L-ascorbic acid metabolic process;6.0;0.8259837884571596;0.7361122068187242;9.405380701177911;115.66137206117003;7.379178354882098;0.003871082034410502;0.7004918368257019;[SLC23A2, CYB5R3, GSTO2]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[PRKCD]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[ITGB2, PRKCD, SOD1]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[HRK, YWHAB, PTEN, PARK7, STK4, THBS1, BBC3, STK3, BCLAF1, CASP8, HYAL2, TP53INP1, TP53BP2, CASP2, CTSH, PLAGL2, RIPK1, BID, GSN, FBXO18, RPS7, TNFRSF12A, RIPK3, CAV1, ATPIF1, PRKCD, PLAUR, G0S2, YWHAZ, TGFBR1, SOD1, CYLD, SFRP1, TFDP1, TFDP2, ADORA2A, PPIF, LTBR, SERINC3, ATF4]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PPP1R15A, CDKN1A, CDC123, PKD2, THBS1, PPM1G, MYC, TP53INP1, ABL1, IL12A, HRAS, CDKN2D, PRNP, TCF7L2, CDKN2C, PNPT1, PRKAB1, TGFBR1, ERN1, CDK6, FAP, RHEB, PRR11, EIF4G2, MCPH1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, TESK2, IGF1R, ZMYM2, STK16, TRIM24, ABL1, NEK1, CSK, TRIM27, EPHB4, PDGFRB, SYK, PRKCD, ERLIN2, CLK4, CLK3, CLK1, BCR, WEE1, FES, KIT, FGFR1OP, PTPN6, TEK, EPHA1, MET, HBEGF]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[TCF7L2, DTX3L, EPB41, BDNF, CAV1, PARK7, TMEM173, STK4, STK3, PPP2CA, GNL3L, CDK5, ABL1, EP300, MAPRE3, TRIB3, MAPRE1, DACT1]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[SLC12A2, CLIC5, SLC26A8, SLC1A4, CLCC1, CLCN3, APOL1, BEST3]
GO:1901387;positive regulation of voltage-gated calcium channel activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;1442.0152551110536;7.474488534686424;0.0482629528590931;0.8146746435927894;[KCNE3]
GO:1902358;sulfate transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;123.29733532969695;7.069023426578259;0.0041266508530873195;0.7365101867784198;[SLC26A8, SLC25A10]
GO:0006641;triglyceride metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.318369324188282;85.59385656069774;5.500407508664414;0.0028647493496168257;0.6322104610454062;[CETP, FABP5, GPAM, CAV1, CAT, DDHD2, MGLL]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[HBZ, RRM1, SEPT11, XRCC6, CPSF6, JUP, RIPK3, YWHAB, TRADD, HBE1, IKZF1, HSD17B8, PRKAB1, GCHFR, BAG4, COL1A2, NUP62, RIPK1, FARSA, HRAS, S100A10, BIRC3]
GO:0035082;axoneme assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;53.25370651110567;6.481236761676141;0.0017823536317024158;0.6823701146576509;[BBS2, SPAG16, UBE2B, TTLL3, IQCG, GAS8]
GO:1903566;positive regulation of protein localization to cilium;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;74.11254383842964;8.390779266560578;0.002480480145313119;0.7800242071602487;[CCDC88A, GAS8]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[BBS2, TCF7L2, OSBPL11, SENP2, METRNL, AACS, PER2, BSCL2, NR4A2, NIPBL, TBL1XR1, FAM120B, ZNF516, EP300, SDF4, SOX8, TRIM32]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[FGA, PLAU, FGG, PLAUR]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRPAP1, CAV1, PRKCD, TFIP11, PARK7, SENP2, EIF2S1, GNL3L, CAMK1, ADNP, DISC1, MET, DACT1]
GO:0055091;phospholipid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.57984905034425;0.0010826797251974863;0.738553198190834;[CETP, GPAM]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CXCL6, CXCL9, ITGB2, LYST, CORO1A, CXCL14, PIK3CG, PREX1, CCL5, NCKAP1L, CCL19, CCR10, CCR2, PDGFRB, HSD3B7, ABCC1, FCER1G, ANXA1, SYK, CCL20, PRKCD, VAV1, IL6, CXCL11, RAB13, KIT, ARHGEF5, HBEGF]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[PRKCD]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[EIF2B4, TCF7L2, XBP1, ENDOG, SERPINF1, PTEN, THBS1, AACS, NME1, ERN1, GPAM, SIN3A, CASP3, PCK2]
GO:0018350;protein esterification;7.0;0.7586651285174919;0.7302519295159464;9.245532000236016;151.15475272427284;9.777073627680469;0.005059013543235805;0.8509193652572005;[CEL]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TWSG1, BMPR2, UBE2D3, GDF1, MEGF8, RUNX2]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[USP13, PLEKHF2, BECN1, RGS19, CALCOCO2, ITGB4, EI24, VPS4B, RAB1B, CLEC16A, PTPN22, PARK7, FNBP1L, CLN3, FUNDC1, CTSK, LAMP2, VPS11, UBQLN1, ABL1, C6orf106, MFN2, TBC1D17, MARK2, ARSB, ATG5, VPS18, GABARAPL1, XBP1, MAP1S, VTA1, ATG10, VPS37A, VPS37B, PGA3, DYNLL2, PRKAB1, PGA5, SIRT2, TM9SF1, VPS41, PLEKHM1, CHMP4B, PIK3C3, ULK1, CHMP6, C9orf72, ATG2B]
GO:2000675;negative regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;7.9853141584524145;0.0043485178181058145;0.8046099625986299;[TCF7L2, WFS1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, CXCL9, DDX41, ZC3HAV1, SAMHD1, LYST, RELA, HYAL2, NLRP3, IFNAR2, DDX17, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, TLR7, SERINC3, APOBEC3A, EXOC1]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[RPS6KA4, CCNB1, RPS6KA5, CDK2, PRKCD, VRK1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[VPS29, CHD8, USP34, PTEN, KLHL12, VPS26A, PRICKLE1, APCDD1, MED12, GNG2, GNAT2, RNF138, MYC, GRK6, AP2S1, SPIN1, DVL3, DISC1, GPC6, MARK2, DACT1, TLE4, TCF7L2, CSNK2A1, UBE2B, RYK, FBXW11, FZD6, SENP2, DDB1, NR4A2, CYLD, BCL9, SFRP1, SFRP2, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1, TNRC6B]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[BMPR2, TWF2, TRAK1, LRP8, RAB21, NCKIPSD, DVL3, SCARF1, MARK2, ARSB, ACTR2, TMEM30A, SEMA4D, TNFRSF12A, BDNF, SERPINF1, RAB11A, NME1, SETX, FES, RUFY3, CAPRIN1, RAPGEF1, CAMK1, ADNP, MEGF8, PAFAH1B1, EZH2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[DIABLO, PDCD6, TRADD, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, CASP8, CASP10, CASP3, NLRP3, CTSH, RIPK1, BID]
GO:0035235;ionotropic glutamate receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.310070521373587;27.195621953761602;6.558197802812269;9.102129923216596E-4;0.6863059058804069;[CLN3, GRIN3A, SULT1A3, CPEB4]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[OXTR, BDNF, ADNP, PDLIM5]
GO:0061001;regulation of dendritic spine morphogenesis;11.0;0.8933024483968273;0.8790801765280758;9.548481544818586;263.40314350006116;6.166155715036245;0.00881586616550832;0.747766442352181;[ACTR2, CDK5, CAPRIN1, CFL1, PTEN, PDLIM5, LRP8, PAFAH1B1]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[PRKCD, NFKB1, RELA]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BCLAF1, PCNA, PAXIP1, FBXO18, DTX3L, EYA2, MYC, CEBPG, PRKCD, TIMELESS, BRCA1]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[TCF7L2, BAG3, TPR, CAMK1, GTSE1, EMD]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, CXCL9, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, PREX1, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, PDE8A, CCR2, PDGFRB, ARHGEF11, CD97, ANXA1, SPHK2, SPHK1, AGTRAP, RHOC, ADRA2C, VAV1, VAV2, RHOB, TIAM2, SFRP1, GAL, SFRP2, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, ATF4, PTGER4, SUCNR1, RGS19, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, P2RY8, ABR, GNG2, RIC8B, TBXA2R, HRH2, CCL5, GRK6, GNG8, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, FZD6, TSHR, BAIAP3, POMC, CXCL11, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, PTPN6, CALM1, CALM2]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[TCF7L2, GNG2, GNAT2, FZD6, CALM1, TNRC6A, TNRC6B]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CXCL6, CXCL9, TNFSF14, SWAP70, THBS1, CXCL14, CREB3, IL6, CXCL11, KARS, IL23A, C1QBP, CCL5, NCKAP1L, IL12A, CCL19, GPSM3, CCR2]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[CD40, CR2, PRKCD, ABL1, IL7R, CARD11]
GO:0002052;positive regulation of neuroblast proliferation;8.0;1.0;0.875;9.628524252492122;500.99868276789744;6.781341354126479;0.016767975042699966;0.7217981122146513;[FOXG1, DISC1]
GO:1905515;non-motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.039404009397101;0.004644879144209681;0.6597747671587765;[BBS2, CENPJ, TMEM107, IFT122, DISC1]
GO:0043950;positive regulation of cAMP-mediated signaling;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;239.5163045814748;6.686031174322154;0.008016395163662574;0.7169239451870815;[CXCL9, CXCL11]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, RAB3D, CRISP3, ITGB2, HK3, PSMD7, ACTR1B, FCGR3B, PLAU, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, CD97, ACTR2, SERPINB1, HLA-H, FCER1G, DBNL, MME, PRKCD, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, PLD1, C3, RAP1B, COMMD9, CYB5R3, ALDH3B1, PSMB1, NCKAP1L, RAB6A, ARSB, AP1M1, CTSA, XRCC6, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[PRNP, TCF7L2, THRA, WFS1, GFI1, CEBPG, FZD6, COMMD1, PKD2, NFKBIA, CYLD, ITCH, NLRP12, BRMS1, ADORA3, TMSB4X, CAT, NLRP2, NLRP3, CDK5RAP3, EZH2, HAVCR2]
GO:0010909;positive regulation of heparan sulfate proteoglycan biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;885.904042282351;8.67846133901236;0.02965041103331486;0.8590579283277371;[TCF7L2]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ANKRD17, FGA, CXCL6, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, SYK, CCL20, CEBPE, PRKCD, DEFB1, RNASE3, NLRC4, LYST, P2RX7, CD4, IL6, IL23A, BCL3, NLRP3, IL12A, HIST1H2BC, HAVCR2]
GO:0042744;hydrogen peroxide catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;235.80375524332874;6.481236761676141;0.007892139478392308;0.6545710619905948;[HBZ, GPX3, PRDX1, CAT, HBE1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, UBE2D3, KIF14, BUB1B, UBE3A, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, FBXW11, UBE4A, RAD23A, KCTD2, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, AMN1, CCNB1, FZR1, ZNRF2, PSMB5, RMND5A, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, MAD2L1]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[CLN3, RAB20, SLC9A6, VPS33A, SLC9A8, ATP6V0A2, SLC26A8, RAB38, CLCN3, GPR89B, TM9SF4]
GO:0051177;meiotic sister chromatid cohesion;6.0;0.811012628672052;0.7286266269261705;9.193206181234276;80.84817799904476;7.697632086000634;0.00270591575899172;0.7167775754447168;[RAD51C, BUB1B, HORMAD1]
GO:2000321;positive regulation of T-helper 17 cell differentiation;13.0;0.9326813400603323;0.9288956347978027;9.611994950540911;2604.3016792955605;7.697632086000634;0.08716363348667819;0.8562122276222088;[IL23A, NFKBIZ, NLRP3, IL12RB1]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[TP53INP1, PRKCD]
GO:0050804;modulation of chemical synaptic transmission;6.0;0.5214636594213398;0.5838521423008144;7.2437010612611035;27.32355736088522;3.9162874042146036;9.144948752636959E-4;0.5233994325676684;[RAB3B, OXTR, MCTP1, EIF4A3, PTEN, ATP2A2, LRP8, AGER, FXR1, RAP1B, RHOT1, HRH2, ABL1, HRAS, NTSR1, SH3GL1, USP46, PRNP, TOR1A, BDNF, PRKCE, CEL, RAB11A, BAIAP3, SSH1, NISCH, CDK5, ADORA2A, KIT, RARA, KRAS, ADNP, RAB3GAP1]
GO:0015914;phospholipid transport;7.0;0.7763722522362496;0.7391054913753253;9.040737587590003;67.00175910617337;5.618190544320798;0.0022424885796152832;0.638233890966345;[P2RX7, SCARB1, CETP, PRELID1, ABCC1, TMEM30A, STARD7, PITPNB, ABCB4, STARD10, ABCA12]
GO:0030299;intestinal cholesterol absorption;8.0;1.0;0.875;9.628524252492122;82.41160815185232;7.57984905034425;0.002758242359210401;0.7626338329336335;[CEL]
GO:0010745;negative regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;114.21841186311113;7.212124270218933;0.0038227874551613377;0.6919486831672181;[NFKBIA, CETP, ITGB3, ITGAV]
GO:0071444;cellular response to pheromone;5.0;0.8653626801206646;0.7229223519212526;9.427853557029971;59.29564851535419;9.777073627680469;0.0019845719931898356;0.7902410118609202;[GNG8]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, CXCL9, GMFB, NCF1, PTEN, SECTM1, IL27, PARK7, METRNL, CXCL14, BICD1, PLAU, NPPA, IL12A, FAM3C, CAPN1, TIMP1, BUD31, PRKCE, PRKCD, FLT3LG, ADRA2C, GAL, SFRP2, IL23A, CHMP6, HBEGF, COPA, EBI3, CLEC12B, AGER, CCL5, CCL19, CMTM7, UBE2I, TNFSF14, CCL20, CD70, BDNF, GDF1, NETO2, KLHL24, POMC, IL6, CXCL11, CDK5, PNOC, SCGB3A1, KCNK3]
GO:0032079;positive regulation of endodeoxyribonuclease activity;9.0;1.0;0.896240625180289;9.628524252492122;975.1149925155983;8.390779266560578;0.03263622125297896;0.8253454670833372;[PRKCD]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[USP8, CSNK2A1, JUP, CAV1, USP34, NFKB1, ARNTL, DEPDC1B, SFRP1, SFRP2, TBL1XR1, UBR5, ABL1, SPIN1, DISC1, DACT1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, CAMK2D, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, STK38, MKNK2, STK38L, RIPK1, MARK2, SYK, PRKCE, PRKCD, EIF2AK3, CDC7, VRK1, VRK2, MASTL, TGFBR1, MAPK13, CLK1, ERN1, CDK5, CAMK4, CDK2, ULK1, PKN2, CAMK1, CSNK1G2, CSNK1G1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CAMK2D, CSNK2A1, ROCK2, CAD, PRKCD, VRK1, OXSR1, TGFBR1, CLK1, CDK5, ULK1, CAMK1, MARK2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CXCL6, SCARB1, GPI, CD40, CXCL9, BMPR2, ONECUT2, DOCK8, ITGB3, PDCD6, CIB1, MIA3, CXCL14, IGF1R, PREX1, NIPBL, PLAU, C1QBP, TMSB4X, CTSH, IL12A, ITGAV, CPNE3, ATP7A, GTSE1, HRAS, GPSM3, CCR2, SEMA6B, PDGFRB, ANXA1, IGFBP5, ITGA2, SPHK1, SWAP70, PRKCE, TGFBR1, RHOB, PTP4A1, CREB3, KARS, IL23A, RUFY3, KIT, MYADM, EPHA1, MAPRE1, MET, CBLL1, HBEGF, CD151, SEMA3C, ROCK2, CD99L2, THBS1, CORO1A, BAG4, CCL5, ABL1, NCKAP1L, CCL19, AAMP, CLASP1, MAP3K3, XBP1, ANGPT1, SEMA4D, TNFSF14, CCL20, SEMA4B, RAB11A, SSH1, VIL1, IL6, CXCL11, P2RX4, SP1, FGFR1OP, TEK, TRIM32]
GO:0034372;very-low-density lipoprotein particle remodeling;8.0;1.0;0.875;9.628524252492122;84.48067407688755;7.57984905034425;0.0028274921336828916;0.7626338329336335;[CETP]
GO:0034375;high-density lipoprotein particle remodeling;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;83.38206178822108;6.943860283624253;0.0027907225690680937;0.7060287030842711;[SCARB1, CETP]
GO:0034374;low-density lipoprotein particle remodeling;7.0;1.0;0.8509193652572005;9.628524252492122;83.38206178822108;7.212124270218933;0.0027907225690680937;0.7197477358342742;[CETP]
GO:0032350;regulation of hormone metabolic process;4.0;0.556709148698489;0.5283545743492445;7.549082710812286;21.454741332586455;6.250713103064308;7.180708843880517E-4;0.5696617587785947;[TCF7L2, GAL, GFI1, ARNT, NFKB1]
GO:0043046;DNA methylation involved in gamete generation;10.0;1.0;0.9152410118609203;9.628524252492122;410.98998799801075;6.781341354126479;0.013755465031318019;0.7620391240755716;[PIWIL4]
GO:0044258;intestinal lipid catabolic process;5.0;1.0;0.7902410118609202;9.628524252492122;44.75739413340951;9.777073627680469;0.001497989702605633;0.7902410118609202;[CEL]
GO:0003351;epithelial cilium movement;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.364546253447678;6.641579411751319;7.15052136259578E-4;0.6298916918429109;[SPA17, GAS8]
GO:1901687;glutathione derivative biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.55953138100517;153.56954054457893;6.686031174322154;0.005139834318413505;0.6321649570480018;[GSTK1, GSTO2]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, BCL9, TCF7L2, CREBBP, HDAC1, RBBP5, MYC, EP300]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, UBE2D3, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, TRIM27, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, RUNX1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, WDTC1, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, NR4A2, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CC2D1B, CIITA, BTG2, THRA, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, EED, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, CXXC5, LRP8, RELA, DNAJB1, RXRA, DNAJB5, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, TCF7L2, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[ACTR2, G6PD, GSN, SETDB1, PRKCE, PTEN, ITPR2, AACS, SOD1, POLB, EEF1B2, CASP8, GRIN3A, TBXA2R, TP53INP1, CAT, RARA, SDF4, PEMT]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C3, CR2, CFH, C1QBP, A2M, CFB, C1QC, C2]
GO:0030207;chondroitin sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.79540990145875;7.138016298065211;0.01378242177759377;0.7400384854347593;[ARSB]
GO:0043691;reverse cholesterol transport;8.0;1.0;0.875;9.628524252492122;39.64151019485986;6.943860283624253;0.001326765671179004;0.7301093378270707;[SCARB1, CETP]
GO:0043570;maintenance of DNA repeat elements;7.0;0.811012628672052;0.7564256795932265;9.446202695698167;170.28329447847625;8.16763571524637;0.005699228621179078;0.7686126355688037;[TCF7L2, MSH3]
GO:0060629;regulation of homologous chromosome segregation;9.0;0.8259837884571596;0.8092325194088689;9.434368238051164;83.9222570118397;9.083926447120524;0.0028088024170584707;0.8607930461318132;[HORMAD1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[BECN1, PCNA, ANXA1, PRKCD, PARK7, RELA, AQP1, RHOB, MAPK13, SETX, IL6, PPIF, ABL1, ECT2, EZH2, MAP3K5]
GO:0014910;regulation of smooth muscle cell migration;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;40.03709713961528;5.71663061713405;0.0013400056102148314;0.6432681208679463;[PDGFRB, IGFBP5, PLAU, ITGA2, CCL5, ATP7A, SSH1]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[CNOT4, ITCH, RNF213, UBE2B, DTX3L, UBE2T, UBE2D3, UBE3A, BRCA1, KLHL24]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[TBX1, OXTR, PTEN, GNG8, CIC]
GO:0009062;fatty acid catabolic process;8.0;0.6763753087927167;0.7131876543963583;8.97982883450301;428.6405088203361;5.244474134527214;0.014346212078803813;0.6432026511327102;[ACOT7, ECHS1, ABCD3, HSD17B4, ETFA, ETFB, CEL, MCAT, ALDH3A2, ACOX2, CPT2, SLC27A2, HIBCH, PCK2]
GO:1902260;negative regulation of delayed rectifier potassium channel activity;12.0;1.0;0.9481203125901445;9.628524252492122;1503.3881939300709;7.8311634786251565;0.05031704988930664;0.8486063770733797;[KCNE3]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, UBR5, UBE2D3, SYVN1, UBE3A, RFFL, MARCH6, TRIM32]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, HLA-H, CAMK2D, PRKCD, HLA-C, HLA-A, HLA-F, IRF4, HLA-DPB1, NCAM1, HLA-DRB3, HLA-DQA1, HLA-DPA1, HLA-DQB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, CPNE1, SOX8, TRIM27, SOX6, IER5, ATXN7L3, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, RUNX1, EID1, EWSR1, RFX4, HOXB4, TRIB3, BCORL1, ASF1B, SF1, ATF4, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, ZNF23, RPAP1, ZNF24, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, PPARGC1B, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, ZNF813, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, CC2D1B, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, HOXC10, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, SCML4, C1QBP, HYAL2, MLX, SPIN1, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPHLN1, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF234, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, DEDD, ZNF101, ZNF585A, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ZNF33A, GFI1B, NFIA, NFIB, NFIC, MARS, PKN2, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, STK16, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF561, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, ZNF302, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, CBX3, NONO, NFXL1, CNOT10, NFKB1, CDK9, NR4A2, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, ZNF655, CNOT8, TMEM18, MNAT1, ZNF654, BRWD1, ZNF532, ZNF410, NFE2L1, ZSCAN2, ZNF652, PHF19, NFKBIB, PHTF2, CIITA, BMPR2, ONECUT2, THRA, CHD9, CHD8, CDCA7L, CHD7, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, NFKBIZ, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, MKL2, KLF11, KLF12, TBP, KLF13, RFC1, EED, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, POLR1B, ZNF638, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPE, CEBPG, CXXC5, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, ASCC3, RBBP7, POLR2I, E2F6, E2F7, POLR2K, ZNF189, E2F8, TCFL5, ZNF286A, TBX1, POLR2J3, SPEN, TCF7L2, CHURC1, EYA2, CDC5L, ARID3B, DEK, USF2, PNRC1, MAPK13, PNRC2, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, SSBP3, TRIM33]
GO:0060294;cilium movement involved in cell motility;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.364546253447678;7.004484905440688;7.15052136259578E-4;0.6484506956670166;[SPAG16, GAS8]
GO:0038166;angiotensin-activated signaling pathway;6.0;0.8653626801206646;0.7558016526504768;9.4949928598676;26.976932752798508;7.474488534686424;9.028936615729279E-4;0.7053660038532718;[AHCYL1, CAV1, AGTRAP]
GO:0051480;regulation of cytosolic calcium ion concentration;10.0;0.6634067003016617;0.7469443620117512;9.01761517016915;288.6919123283276;4.053488525728088;0.009662258499776054;0.6225366035731486;[PTGER4, OXTR, CXCL9, ITPR2, PKD2, PIK3CG, P2RY8, CLN3, GNAT2, TBXA2R, ABL1, CDH23, PDE6B, ITGAV, CCL19, NTSR1, CCR10, GTF2I, CCR2, CAV1, SWAP70, PRKCE, GPR55, ATP2B4, P2RX7, CD4, P2RX5, CXCL11, P2RX4, CALM3, CALM1, CD24, CALM2, KCNK3, PVALB]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[CYFIP2, NCKAP1, VPS29, OXTR, MAML1, WIPF2, PKD2L1, TIAL1, RPS6KA4, NSDHL, RPS6KA5, RASSF2, GNAT2, MYC, HOMER3, IL12A, CPNE3, EPHB4, HLA-H, CSNK2A1, PRKCE, PRKCD, FLT3LG, HLA-C, TALDO1, HLA-A, HLA-F, RUNX2, RC3H2, BCR, SFRP1, TWSG1, SFRP2, KARS, IL23A, DDIT4, PSME2, EPHA1, TLN1, EBI3, VPS26A, APCDD1, CRHR1, IL22RA2, MTDH, SGPL1, TSPAN7, TSPAN4, ATP6V0A2, NCKAP1L, TSPAN2, HLA-DQA1, CCR10, SULT1A3, PAG1, BBS2, CREBBP, SIVA1, TNFSF14, RCC2, FZD6, EIF2AK3, GDF1, PILRB, PILRA, SETX, CYLD, COL1A2, GRIN3A, SDC1, CALM1, HLA-DRB3, CD24, CPEB4, ARF4, CDKN1A, CD40, SIGLEC9, ARPC1A, IL27, WASL, PTPRK, MED12, CASP10, TMSB4X, SPIN1, CTLA4, TIMP1, HRAS, CCR2, HLA-DPA1, APPL1, FCER1G, ANXA1, CAMLG, TNFRSF12A, SYK, PARP2, ROM1, PDCD1LG2, BTN3A2, GFRA2, SIRT2, VAV1, VAV2, DDB1, ITPKB, KIT, RAPGEF1, TAX1BP3, RHOU, HBEGF, HLA-DQB1, NOTCH2NL, WAS, NEDD9, PRICKLE1, LILRA2, AKAP2, RELA, RNF138, PERP, AP2S1, CCL19, BID, IL12RB1, DISC1, GPC6, DEDD, MAP3K3, MAP3K1, CCL20, CD70, RYK, G0S2, MYO9B, LILRB3, MIB1, ITCH, CENPJ, HLA-DPB1, PLP2, MEGF8, LIMS1, GALNT11, SCARB1, DGKD, NCF1, NCF2, CD80, PDCD6, UBE2D3, IL5RA, CIB1, RORA, IGF1R, ADORA3, NPPA, CFL1, EP300, TLE4, IFNAR2, SEMA6B, PDGFRB, CD97, LAG3, IL4R, FBXW11, DOK2, SLC9A6, CD8B, CCNE1, MADD, ELMO1, CSNK1G2, CARD11, CSNK1G1, CD151, DIABLO, DTX2, KLHL12, ADIPOR2, CORO1A, EFNA4, AGER, RASGRP4, HSP90B1, RAP1B, NCKIPSD, FUT8, BAG4, BAG3, BAG1, GRK6, ABL1, DVL3, RIPK1, CD300LF, MARK2, ATP6V1F, FAM83A, EIF2B4, UBE2B, BTN2A1, BDNF, IFT122, TNFRSF10B, MSN, TNFRSF10A, NFKB1, VIL1, NFKBIA, NR4A2, BCL9, IL6, CXCL11, ARPC2, PTPRA, FES, GNAQ, BRWD1, IL7R, ITGB1, CXCL6, CIITA, CXCL9, BMPR2, ITGB4, ITGB3, CHD8, TRADD, ITGB2, USP34, PTEN, PTPN22, ITGAE, PTBP1, FCGR3A, CLEC1A, CASP8, CASP3, NUP62, NFKBIZ, CASP2, ITGAV, DACT1, ACTR2, CR2, ITGA2, PLAUR, IRAK4, SENP2, YWHAZ, SEPT2, TGFBR1, DUSP22, ADORA2A, ITGAD, IRF4, MYH9, LCP2, LCP1, DAGLB, MET, BIRC3, LAMA5, STOML2, CAMK2D, SEMA3C, ROCK2, CLEC12B, IL2RG, SAMHD1, LRP8, P2RY8, CLN3, GNG2, POLR2B, CCL5, MKNK2, IL21R, POLR2E, POLR2G, NCAM1, CSK, POLR2I, SH2B2, POLR2K, SPEN, TCF7L2, ANGPT1, SEMA4D, EYA2, MX2, SEMA4B, SHCBP1, TSHR, SOD1, P2RX7, POMC, CD4, KLF6, P2RX5, P2RX4, TNIP2, TSPAN17, CD9, CCM2, MNDA, KRAS, PTPN6, TEK, LTBR, TNRC6A, TNRC6B]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[DDB1, RNF20, UBE2B, DTX3L, MGRN1, UBE2T, UBE2D3, KLHL12, KBTBD8, ATXN7L3, RNF40]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, TRIM27, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, ZNF18, MEF2B, ZNF282, FLT3LG, RFX1, ZNF12, HCFC2, MED6, RUNX2, RC3H2, THAP1, RUNX1, EID1, THAP6, SFRP1, TWSG1, SFRP2, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ANKRA2, ATF4, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF23, ZNF24, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, ZBED1, HIVEP2, PPARGC1B, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, JUP, ZNF260, BCL11A, PBX3, EAF2, GDF1, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, ZNF813, RCOR3, ZNF136, PAM, EZH2, CC2D1B, ARF4, AHCTF1, BTG2, CDKN1A, CD40, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, HOXC10, MED12, NIPBL, ZMYM2, C1QBP, HYAL2, MLX, CIC, JARID2, HRAS, TEAD2, HAVCR2, ZNF485, BRD3, TSC22D4, HBZ, NCOA6, TSC22D3, TSC22D2, SIRT7, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, RARA, ZNF234, ZNF350, GPS2, NEDD8, ZNF2, NOC4L, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, PLAGL2, ZNF101, ZNF585A, ZNF462, EGLN2, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ZNF33A, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, MEGF8, KIAA1958, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, UBE2D3, ARID4A, UBP1, ZBTB20, RORA, YEATS4, UBE3A, PARK7, YY1, STK16, WWC3, EP300, HMGN3, ZNF564, GTF2I, TLE4, ZNF441, ZNF561, ZNF680, SSU72, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, ZNF302, BPTF, WDTC1, TFAP2A, ZBTB17, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFXL1, NFKB1, CDK9, NFKBIA, NR4A2, BCL9, CDK8, IL6, TFCP2, COPS5, CNOT7, YEATS2, CNOT1, SP1, SP4, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, ZNF655, MNAT1, ZNF654, BRWD1, ZNF532, ZNF410, NFE2L1, ZSCAN2, ZNF652, CIITA, BMPR2, ONECUT2, THRA, CHD8, CHD7, DDX41, LDB2, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, NFKBIZ, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, MKL2, KLF11, KLF12, TBP, KLF13, RBM15, PPP1R12A, PEG3, RFC1, H2AFY, EED, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, ZNF516, LCOR, ZNF511, EAPP, MET, MCPH1, SMARCD2, CAMK2D, HDAC3, HDAC1, WBP2, CEBPE, CEBPG, CXXC5, LRP8, DNAJB1, DNAJB5, SAP18, ZNF622, RBBP7, MTA2, E2F6, E2F7, ZNF189, E2F8, TCFL5, ZNF286A, IRX1, TBX1, SPEN, TCF7L2, SEMA4D, ATP2B4, CDC5L, FBXL15, ARID3B, DEK, USF2, POMC, KLF6, TNIP1, TNIP2, ASXL2, TAF7, TAF4, SSBP3, TRIM33]
GO:0051598;meiotic recombination checkpoint;9.0;1.0;0.896240625180289;9.628524252492122;404.9258988516973;8.390779266560578;0.01355250542491682;0.8253454670833372;[HORMAD1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, TCF7L2, HDAC1, CAV1, CHD8, FZD6, KLHL12, PRICKLE1, STK4, STK3, CYLD, SFRP1, SFRP2, RAPGEF1, DVL3, EMD, DACT1]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[PEX16, GSTK1, PEX19, UBE2D3, HSD17B4, DHRS4, ACOX2, AGPS, CAT, ACOT2, LONP2, SLC27A2, ACOT4, RAB8B]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CXCL6, CD40, CXCL9, CEBPE, GFI1, CD80, RELA, PABPN1, NLRP7, TBXA2R, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, PDCD1LG2, NFKB1, BCR, IL6, CXCL11, TNIP1, TNIP2, RARA, NFKBIB]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[VIL1, GSN, CAPZB, TMSB4X, PRKCD, MYADM, TWF2, SPTB]
GO:0048477;oogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;84.68474556890583;6.481236761676141;0.002834322222868324;0.6216917612613706;[H3F3A, HORMAD1]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CXCL6, CXCL9, CXCL11, CCL20, CCL5, CIB1, CCL19, CCR10, CCR2]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[GSTK1, G6PD, GSTA5, ALDH5A1, GSTO2, CTNS, CHAC2, PARK7, MMACHC, GDAP1, CNDP2, SOD1]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CYFIP2, CCNF, PREP, UBE2L3, PSMD8, PSMD7, PSMD4, CAPNS2, PSMD2, CDC26, MYC, CPNE1, LONP2, SKP2, ATXN7L3, ARRDC1, SFRP1, KCTD10, PSME2, CFB, COPS7B, COPS7A, ANAPC11, C2, C3, RHOT1, RNF213, AMZ2, CTSA, XBP1, EDEM1, LNPEP, ERLIN2, PGA3, PGA5, CYLD, RNF103, NPLOC4, CDC16, FBXL3, WDR48, PPP1R11, KIF14, OTUD7B, BRCA1, TRIM9, CTSO, CASP10, CTSK, CTSH, CTSE, SEC13, MME, JOSD1, SIRT2, DDB1, PSMA1, MMP23A, MPND, DERL3, GPS1, DERL2, NEDD8, TANK, PSMA7, RELA, ARNTL, AMN1, ADAM28, PSMB5, PERP, PSMB1, ADAM23, MBD6, LRRC29, SYVN1, KBTBD4, ITCH, SPSB1, SPCS2, FAP, PSMC1, C1QC, MAD2L1, PDCD6, UBE2D3, BUB1B, UBE3A, PARK7, UBE2Z, CNDP2, YY1, NPEPPS, PLAU, CAPN2, PMPCB, CAPN1, C18orf25, USP8, MYLIP, RNF44, FBXO18, FBXW11, UBE4A, KCTD2, TRPC4AP, KCTD5, CDC25A, RNF40, TBL1XR1, CHMP4B, ANAPC5, UBR4, HSP90B1, VCPIP1, CCNB1, DPP8, UBD, UBR5, NLRP3, USP51, RIPK1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, RHBDD2, RHBDD1, BTBD6, MARCH6, NFKB1, NFKBIA, NSFL1C, COPS5, TPP1, USP36, USP37, USP38, USP32, USP34, PTEN, ECE2, USP39, SENP6, POLB, CASP8, SCRN1, CASP3, CASP2, USP46, FGA, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, VPS37A, SENP2, TGFBR1, ESPL1, MYH9, PIK3C3, MAN1B1, USP41, THOP1, BIRC3, USP13, BECN1, STOML2, VPS4B, RNF38, USP12, LRP8, PARL, PSMB10, TFPT, CLN3, FZR1, ZNRF2, RMND5A, TP53INP2, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, MBTPS1, FBXL15, FBXL16, CAPN13, P2RX7, CAPN11, XPNPEP1, TNIP1, TNIP2, ASXL2, TRIM32, OTUD1, METAP2]
GO:0045880;positive regulation of smoothened signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;187.6437959822434;6.343086423195323;0.006280268983073171;0.6753050999230941;[SFRP1, TUBD1, GAS8]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT12, GALNT11, ST6GAL1, GALNT1, ST3GAL1, GALNT10]
GO:0019532;oxalate transport;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;53.14108600855652;7.292166977892469;0.0017785843248339678;0.769162383550154;[SLC26A8]
GO:0030157;pancreatic juice secretion;6.0;1.0;0.8231203125901445;9.628524252492122;60.48885175748684;7.8311634786251565;0.0020245074318908153;0.7236063770733796;[COPA, CEL, AQP1]
